Načítá se...
Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment
The sites of targeted therapy are limited and need to be expanded. The FGF‐FGFR signalling plays pivotal roles in the oncogenic process, and FGF/FGFR inhibitors are a promising method to treat FGFR‐altered tumours. The VEGF‐VEGFR signalling is the most crucial pathway to induce angiogenesis, and inh...
Uloženo v:
| Vydáno v: | Cell Prolif |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8016646/ https://ncbi.nlm.nih.gov/pubmed/33655556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.13009 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|